Related Experiment Video
Updated: Jul 29, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in
Gianluca Pontone1, Andrea Igoren Guaricci2, Laura Fusini3
1Centro Cardiologico Monzino IRCCS, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Insights
Cardiac magnetic resonance (CMR) improves risk prediction for sudden cardiac death in ischemic cardiomyopathy patients compared to echocardiography. This advanced imaging helps identify individuals who would benefit most from implantable cardioverter-defibrillator therapy.
Area of Science:
- Cardiology
- Medical Imaging
- Preventive Medicine
Background:
- Implantable cardioverter-defibrillator (ICD) therapy is standard for preventing sudden cardiac death (SCD) in ischemic cardiomyopathy (ICM) with left ventricle ejection fraction (LVEF) ≤35%.
- Current guidelines face challenges due to low ICD intervention rates and SCD occurrences in eligible patients.
Purpose of the Study:
- To evaluate the Net Reclassification Improvement (NRI) of using cardiac magnetic resonance (CMR) versus transthoracic echocardiography (TTE) for ICD implantation indications in ICM patients.
- To assess the predictive value of CMR parameters for major adverse arrhythmic cardiac events (MAACE).
Main Methods:
- The DERIVATE-ICM registry enrolled 861 patients with ICM and chronic heart failure (TTE-LVEF <50%).
- Patients underwent both TTE and CMR imaging.
- Major adverse arrhythmic cardiac events (MAACE) were tracked as primary endpoints during a median follow-up of 1,054 days.
Main Results:
- MAACE occurred in 10.2% of patients.
- Independent predictors of MAACE included left ventricular end-diastolic volume index, CMR-LVEF, and late gadolinium enhancement (LGE) mass.
- A multiparametric CMR score demonstrated a significant NRI of 31.7% compared to the TTE-LVEF cutoff of 35% for predicting MAACE.
Conclusions:
- The DERIVATE-ICM registry highlights the added value of CMR in risk stratification for MAACE in ICM patients.
- CMR provides superior risk stratification compared to standard TTE for guiding ICD implantation decisions.
- Multiparametric CMR assessment enhances the identification of high-risk patients for primary prevention of SCD.
Background:
Implantable cardioverter-defibrillator (ICD) therapy is the most effective prophylactic strategy against sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM) and left ventricle ejection fraction (LVEF) ≤35% as detected by transthoracic echocardiograpgy (TTE). This approach has been recently questioned because of the low rate of ICD interventions in patients who received implantation and the not-negligible percentage of patients who experienced SCD despite not fulfilling criteria for implantation.
Objectives:
The DERIVATE-ICM registry (CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy; NCT03352648) is an international, multicenter, and multivendor study to assess the net reclassification improvement (NRI) for the indication of ICD implantation by the use of cardiac magnetic resonance (CMR) as compared to TTE in patients with ICM.
Methods:
A total of 861 patients with ICM (mean age 65 ± 11 years, 86% male) with chronic heart failure and TTE-LVEF <50% participated. Major adverse arrhythmic cardiac events (MAACE) were the primary endpoints.
Results:
During a median follow-up of 1,054 days, MAACE occurred in 88 (10.2%). Left ventricular end-diastolic volume index (HR: 1.007 [95% CI: 1.000-1.011]; P = 0.05), CMR-LVEF (HR: 0.972 [95% CI: 0.945-0.999]; P = 0.045) and late gadolinium enhancement (LGE) mass (HR: 1.010 [95% CI: 1.002-1.018]; P = 0.015) were independent predictors of MAACE. A multiparametric CMR weighted predictive derived score identifies subjects at high risk for MAACE compared with TTE-LVEF cutoff of 35% with a NRI of 31.7% (P = 0.007).
Conclusions:
The DERIVATE-ICM registry is a large multicenter registry showing the additional value of CMR to stratify the risk for MAACE in a large cohort of patients with ICM compared with standard of care.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy III: Hypertrophic Cardiomyopathy